Share on StockTwits

Vitamin Shoppe (NYSE:VSI) has been given a consensus rating of “Buy” by the thirteen brokerages that are presently covering the company, Analyst Ratings reports. Five research analysts have rated the stock with a hold rating, six have given a buy rating and one has issued a strong buy rating on the company. The average twelve-month target price among brokerages that have issued a report on the stock in the last year is $52.84.

A number of analysts have recently weighed in on VSI shares. Analysts at Morgan Stanley initiated coverage on shares of Vitamin Shoppe in a research note on Tuesday, June 24th. They set an “overweight” rating and a $54.00 price target on the stock. Separately, analysts at Bank of America upgraded shares of Vitamin Shoppe from an “underperform” rating to a “neutral” rating in a research note on Wednesday, June 4th. They now have a $47.00 price target on the stock. Finally, analysts at Barclays upgraded shares of Vitamin Shoppe from an “equal weight” rating to an “overweight” rating in a research note on Friday, May 9th. They now have a $51.00 price target on the stock, up previously from $49.00.

Vitamin Shoppe (NYSE:VSI) opened at 43.39 on Tuesday. Vitamin Shoppe has a 52-week low of $39.92 and a 52-week high of $55.20. The stock has a 50-day moving average of $43.7 and a 200-day moving average of $45.24. The company has a market cap of $1.314 billion and a price-to-earnings ratio of 19.52.

Vitamin Shoppe (NYSE:VSI) last posted its quarterly earnings results on Wednesday, May 7th. The company reported $0.67 EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.68 by $0.01. The company had revenue of $307.80 million for the quarter, compared to the consensus estimate of $302.82 million. During the same quarter in the prior year, the company posted $0.72 earnings per share. The company’s quarterly revenue was up 10.3% on a year-over-year basis. Analysts expect that Vitamin Shoppe will post $2.42 EPS for the current fiscal year.

Vitamin Shoppe, Inc is a specialty retailer and direct marketer of vitamins, minerals, herbs, specialty supplements, sports nutrition and other health and wellness products.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.